inPractice® - Clinical Trial Data

Timing of Initiation of First-line Antiretroviral Therapy

Authors: Marshall J. Glesby, MD, PhD; Timothy J. Wilkin, MD, MPH (More Info)
Section Editor: Joel E. Gallant, MD, MPH
Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
Last Reviewed: 4/1/16 (What's New)

Summary

Data from the SMART study, HPTN 052, the CHER trial, CIPRA HT001 trial, TEMPRANO trial, and the START trial support earlier ART initiation at higher CD4+ counts (Table 3)^{[Grinsztejn 2014; SMART 2006; SMART 2008a; SMART 2008b; Cohen 2011; Violari 2008; Severe 2010; TEMPRANO 2015; INSIGHT START 2015]}

Action required

Login now to access all of your entitled content
or
View additional options to gain access to this content

Keywords: Initial Antiretroviral Therapy